Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Confirmatory Phase 2 Study

Clinical and Experimental Nephrology - Japan

doi 10.1007/s10157-019-01818-2